Techfields Pharma is a leading clinical stage pharmaceutical company focused on a completely new direction in the development of medicines for inflammatory diseases, autoimmune diseases, cardiovascular diseases, metabolic diseases, depression, and aging-related diseases. Our efforts have produced a novel transdermal drug delivery platform that allows drugs to penetrate skin, blood-brain, blood-milk, and other membrane barriers literally thousands of times faster and have a pharmacological effect hundreds of times stronger than their parent drugs – not only vastly increasing the effect of current treatments, but also making previously incurable diseases curable.
Science and Innovation
Techfields continues to advance novel small molecule compounds to create new solutions to unmet medical problems. Techfields utilizes advanced technologies to enhance its drug discovery capabilities and to accelerate the drug development process.
Chongxi Yu, Founder/CEO, Ph. D.
Chongxi Yu Ph.D is a founder and served as CEO of Techfields Pharma. Dr. Yu is the first who put forward a new theory about drug absorption, and through years of effort, he has not only proved the correctness of the theory, but also established a new platform of transdermally delivering drugs according to it. Dr. Yu received Ph.D degree in Bioorganic Chemistry from the State University of New Jersey, US. Dr. Yu worked as a postdoctoral associate in University of Kentucky and then in University of Minnesota from June,
Thomas A. Dahl, Ph.D.
Thomas A. Dahl Ph.D. was resposible for Operational Affairs of Techfields Pharma. from 2013. Dr. Dahl was an accomplished biotech/pharma executive with expertise in early stage ventures, including technical and market analysis of products and technologies, fundraising, business strategy and operationalization, development program strategy, clinical trial design and interpretation, and presentation to funding communities, analysts and pharma partners. Dr. Dahl also took senior management positions, including President, CEO, and COO, in a number of emerging companies which had enjoyed the success of acquisition, partnership or becoming public entities through IPO or reverse merger. Thomas A. Dahl received his Ph.D. degree in Genetics and Biochemistry from the Johns Hopkins University, USA.
Lina Xu, Co-Founder/Vice President, M.S. in Chemistry from Zhejiang University. She has 8 years of experience in drug research and development. with rich experience in new product development and project management, she mainly assists Dr. Yu with his work, responsible for new drug development and patent application as well as daily affairs management of the company.
Derek (Yuanchao) Zhang Ph.D.
Derek (Yuanchao) Zhang Ph.D. is resposible for Regulatory Affairs of Techfields Pharma. Dr. Zhang has 14 years of experience in drug research, development and regulatory approval, including 4 years of industrial experience at Pfizer and over 6 years of regulatory experience at the FDA. Dr. Zhang was Senior Clinical Pharmacology Reviewer in the Office of Clinical Pharmacology, the Center for Drug Evaluation and Research, the Food and Drug Administration. He successfully reviewed numerous NDAs (including several NME NDAs and BLAs), NDA supplements, and IND submissions. Dr. Zhang also contributed to several guidance document development and revision. Dr. Zhang received his Ph. D in bioengineering and therapeutics from the University of California, San Francisco (UCSF), US.
Gustavo A. Poveda Marin
Gustavo A. Poveda Marin, responsible for Phase I-IV Clinical Study, B.Sc. in microbiology from the University of Texas at Austin, USA. He has over 20 years of experience in conducting clinical research & clinical trials. He was responsible for Phase I-IV clinical study projects, including both domestic and global trials.
Cathy Yu. Lawyer, JD,
Dr. Cathy Yu was responsible for the legal afire of Techfields Pharma.. Dr. Yu has a solid theoretical foundation and has extensive working experience in legal affairs. Dr. Yu has been involved in the drafting of various legal documents and attended relevant conference events on behalf of Congress members. Dr. Yu has an ability of keen insight and deep analysis to all kinds of legal provisions expressed. Cathy Yu received her Juris Doctor degree from the University of Chicago Law School, US.